2006 Annual Meeting | Neuroimaging in Clinical Trials of Parkinson's Disease: What Does It All Mean?

Date Monday 04/03/06

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) John C. Morgan, MD, PhD

Topic(s) Imaging

Learning Objectives Upon Completion:
Participants should understand the rationale for the use of RTI as a primary or surrogate outcome measure in the CALM-PD, REAL-PET and ELLDOPA clinical trials; understand why clinical and RTI outcome measures may appear disparate in these trials; and understand the role that nigrostriatal RTI may play in future clinical trials in PD.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse, Other

Event Timeline
06:45 AM - 07:30 AM		Rationale, Design and Clinical Outcomes of CALM-PD, REAL-PET, and ELLDOPA John C. Morgan, MD, PhD
06:45 AM - 08:30 AM		Breakfast
07:35 AM - 08:20 AM		Radiotracer Imaging Outcomes in CALM-PD, REAL-PET, and ELLDOPA and the Future of Radiotracer in PD Clinical Trials Andrew S. Feigin, MD
08:20 AM - 08:30 AM		Questions and Answers

Faculty Disclosures
John C. Morgan, MD, PhD	Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Morgan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Civil Cases. Dr. Morgan has received personal compensation in the range of $5,000-$9,999 for serving as a Rater with Praxis.
Andrew S. Feigin, MD	Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.

��ɫ��

��ɫ��